Steve Miller - 21 Nov 2024 Form 4 Insider Report for CATALYST PHARMACEUTICALS, INC. (CPRX)

Role
Chief Op. & Scientific Officer
Signature
/s/ Steve Miller
Issuer symbol
CPRX
Transactions as of
21 Nov 2024
Net transactions value
$0
Form type
4
Filing time
25 Nov 2024, 17:01:04 UTC
Previous filing
22 Aug 2024
Next filing
11 Dec 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CPRX Options to purchase common stock Award $0 +202,958 +13% $0.000000 1,824,247 21 Nov 2024 Common Stock 202,958 $21.12 Direct F1
transaction CPRX Restricted Stock Units Award $0 +24,801 +1.4% $0.000000 1,849,048 21 Nov 2024 Common Stock 24,801 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Derivative securities vest in equal tranches, 1/3rd on November 21, 2025, 1/3rd on November 21, 2026 and 1/3rd on November 21, 2027.
F2 Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting.
F3 Shares of common stock will be delivered to the Reporting Person upon vesting.